Skip to main content
Top
Published in: Arthritis Research & Therapy 3/2009

Open Access 01-06-2009 | Research article

Early and long-standing rheumatoid arthritis: distinct molecular signatures identified by gene-expression profiling in synovia

Authors: Thierry Lequerré, Carine Bansard, Olivier Vittecoq, Céline Derambure, Martine Hiron, Maryvonne Daveau, François Tron, Xavier Ayral, Norman Biga, Isabelle Auquit-Auckbur, Gilles Chiocchia, Xavier Le Loët, Jean-Philippe Salier

Published in: Arthritis Research & Therapy | Issue 3/2009

Login to get access

Abstract

Introduction

Rheumatoid arthritis (RA) is a heterogeneous disease and its underlying molecular mechanisms are still poorly understood. Because previous microarray studies have only focused on long-standing (LS) RA compared to osteoarthritis, we aimed to compare the molecular profiles of early and LS RA versus control synovia.

Methods

Synovial biopsies were obtained by arthroscopy from 15 patients (4 early untreated RA, 4 treated LS RA and 7 controls, who had traumatic or mechanical lesions). Extracted mRNAs were used for large-scale gene-expression profiling. The different gene-expression combinations identified by comparison of profiles of early, LS RA and healthy synovia were linked to the biological processes involved in each situation.

Results

Three combinations of 719, 116 and 52 transcripts discriminated, respectively, early from LS RA, and early or LS RA from healthy synovia. We identified several gene clusters and distinct molecular signatures specifically expressed during early or LS RA, thereby suggesting the involvement of different pathophysiological mechanisms during the course of RA.

Conclusions

Early and LS RA have distinct molecular signatures with different biological processes participating at different times during the course of the disease. These results suggest that better knowledge of the main biological processes involved at a given RA stage might help to choose the most appropriate treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tak PP, Smeets TJ, Daha MR, Kluin PM, Meijers KA, Brand R, Meinders AE, Breedveld FC: Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 1997, 40: 217-225. 10.1002/art.1780400206.CrossRefPubMed Tak PP, Smeets TJ, Daha MR, Kluin PM, Meijers KA, Brand R, Meinders AE, Breedveld FC: Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 1997, 40: 217-225. 10.1002/art.1780400206.CrossRefPubMed
2.
go back to reference Pouw Kraan van der TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, Fero M, Tak PP, Huizinga TW, Pieterman E, Breedveld FC, Alizadeh AA, Verweij CL: Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum. 2003, 48: 2132-2145. 10.1002/art.11096.CrossRefPubMed Pouw Kraan van der TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, Fero M, Tak PP, Huizinga TW, Pieterman E, Breedveld FC, Alizadeh AA, Verweij CL: Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum. 2003, 48: 2132-2145. 10.1002/art.11096.CrossRefPubMed
3.
go back to reference Toonen EJ, Barrera P, Radstake TR, van Riel PL, Scheffer H, Franke B, Coenen MJ: Gene expression profiling in rheumatoid arthritis: current concepts and future directions. Ann Rheum Dis. 2008, 67: 1663-1669. 10.1136/ard.2007.076588.CrossRefPubMed Toonen EJ, Barrera P, Radstake TR, van Riel PL, Scheffer H, Franke B, Coenen MJ: Gene expression profiling in rheumatoid arthritis: current concepts and future directions. Ann Rheum Dis. 2008, 67: 1663-1669. 10.1136/ard.2007.076588.CrossRefPubMed
4.
go back to reference Lindberg J, Klint E, Catrina AI, Nilsson P, Klareskog L, Ulfgren AK, Lundeberg J: Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients. Arthritis Res Ther. 2006, 8: R179-R190. 10.1186/ar2090.PubMedCentralCrossRefPubMed Lindberg J, Klint E, Catrina AI, Nilsson P, Klareskog L, Ulfgren AK, Lundeberg J: Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients. Arthritis Res Ther. 2006, 8: R179-R190. 10.1186/ar2090.PubMedCentralCrossRefPubMed
5.
go back to reference Pohlers D, Beyer A, Koczan D, Wilhelm T, Thiesen HJ, Kinne RW: Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther. 2007, 9: R59-R69. 10.1186/ar2217.PubMedCentralCrossRefPubMed Pohlers D, Beyer A, Koczan D, Wilhelm T, Thiesen HJ, Kinne RW: Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther. 2007, 9: R59-R69. 10.1186/ar2217.PubMedCentralCrossRefPubMed
6.
go back to reference Galligan CL, Baig E, Bykerk V, Keystone EC, Fish EN: Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells correlates with disease activity. Genes Immun. 2007, 8: 480-491. 10.1038/sj.gene.6364400.CrossRefPubMed Galligan CL, Baig E, Bykerk V, Keystone EC, Fish EN: Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells correlates with disease activity. Genes Immun. 2007, 8: 480-491. 10.1038/sj.gene.6364400.CrossRefPubMed
7.
go back to reference Qingchun H, Runyue H, LiGang J, Yongliang C, Song W, Shujing Z: Comparison of the expression profile of apoptosis-associated genes in rheumatoid arthritis and osteoarthritis. Rheumatol Int. 2008, 28: 697-701. 10.1007/s00296-008-0534-7.CrossRefPubMed Qingchun H, Runyue H, LiGang J, Yongliang C, Song W, Shujing Z: Comparison of the expression profile of apoptosis-associated genes in rheumatoid arthritis and osteoarthritis. Rheumatol Int. 2008, 28: 697-701. 10.1007/s00296-008-0534-7.CrossRefPubMed
8.
go back to reference Devauchelle V, Marion S, Cagnard N, Mistou S, Falgarone G, Breban M, Letourneur F, Pitaval A, Alibert O, Lucchesi C, Anract P, Hamadouche M, Ayral X, Dougados M, Gidrol X, Fournier C, Chiocchia G: DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets. Genes Immun. 2004, 5: 597-608. 10.1038/sj.gene.6364132.CrossRefPubMed Devauchelle V, Marion S, Cagnard N, Mistou S, Falgarone G, Breban M, Letourneur F, Pitaval A, Alibert O, Lucchesi C, Anract P, Hamadouche M, Ayral X, Dougados M, Gidrol X, Fournier C, Chiocchia G: DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets. Genes Immun. 2004, 5: 597-608. 10.1038/sj.gene.6364132.CrossRefPubMed
9.
go back to reference Adarichev VA, Vermes C, Hanyecz A, Mikecz K, Bremer EG, Glant TT: Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation. Arthritis Res Ther. 2005, 7: R196-R207. 10.1186/ar1472.PubMedCentralCrossRefPubMed Adarichev VA, Vermes C, Hanyecz A, Mikecz K, Bremer EG, Glant TT: Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation. Arthritis Res Ther. 2005, 7: R196-R207. 10.1186/ar1472.PubMedCentralCrossRefPubMed
10.
go back to reference Lequerré T, Gauthier-Jauneau AC, Bansard C, Derambure C, Hiron M, Vittecoq O, Daveau M, Mejjad O, Daragon A, Tron F, Le Loët X, Salier JP: Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis. Arthritis Res Ther. 2006, 8: R105-R115. 10.1186/ar1924.PubMedCentralCrossRefPubMed Lequerré T, Gauthier-Jauneau AC, Bansard C, Derambure C, Hiron M, Vittecoq O, Daveau M, Mejjad O, Daragon A, Tron F, Le Loët X, Salier JP: Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis. Arthritis Res Ther. 2006, 8: R105-R115. 10.1186/ar1924.PubMedCentralCrossRefPubMed
11.
go back to reference Coulouarn C, Lefebvre G, Derambure C, Lequerré T, Scotte M, François A, Cellier D, Daveau M, Salier JP: Altered gene expression in acute systemic inflammation detected by complete coverage of the human liver transcriptome. Hepatology. 2004, 39: 353-364. 10.1002/hep.20052.CrossRefPubMed Coulouarn C, Lefebvre G, Derambure C, Lequerré T, Scotte M, François A, Cellier D, Daveau M, Salier JP: Altered gene expression in acute systemic inflammation detected by complete coverage of the human liver transcriptome. Hepatology. 2004, 39: 353-364. 10.1002/hep.20052.CrossRefPubMed
13.
go back to reference Thomas PD, Kejariwal A, Guo N, Mi H, Campbell MJ, Muruganujan A, Lazareva-Ulitsky B: Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res. 2006, 34: W645-W650. 10.1093/nar/gkl229.PubMedCentralCrossRefPubMed Thomas PD, Kejariwal A, Guo N, Mi H, Campbell MJ, Muruganujan A, Lazareva-Ulitsky B: Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res. 2006, 34: W645-W650. 10.1093/nar/gkl229.PubMedCentralCrossRefPubMed
14.
go back to reference Pouw Kraan van der TC, Wijbrandts CA, van Baarsen LG, Rustenburg F, Baggen JM, Verweij CL, Tak PP: Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients. Ann Rheum Dis. 2008, 67: 563-566. 10.1136/ard.2007.081950.CrossRefPubMed Pouw Kraan van der TC, Wijbrandts CA, van Baarsen LG, Rustenburg F, Baggen JM, Verweij CL, Tak PP: Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients. Ann Rheum Dis. 2008, 67: 563-566. 10.1136/ard.2007.081950.CrossRefPubMed
17.
go back to reference Edwards CJ, Feldman JL, Beech J, Shields KM, Stover JA, Trepicchio WL, Larsen G, Foxwell BM, Brennan FM, Feldmann M, Pittman DD: Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis. Mol Med. 2007, 13: 40-58. 10.2119/2006-00056.Edwards.PubMedCentralCrossRefPubMed Edwards CJ, Feldman JL, Beech J, Shields KM, Stover JA, Trepicchio WL, Larsen G, Foxwell BM, Brennan FM, Feldmann M, Pittman DD: Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis. Mol Med. 2007, 13: 40-58. 10.2119/2006-00056.Edwards.PubMedCentralCrossRefPubMed
18.
go back to reference Jackson CJ, Arkell J, Nguyen M: Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1). Ann Rheum Dis. 1998, 57: 158-161. 10.1136/ard.57.3.158.PubMedCentralCrossRefPubMed Jackson CJ, Arkell J, Nguyen M: Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1). Ann Rheum Dis. 1998, 57: 158-161. 10.1136/ard.57.3.158.PubMedCentralCrossRefPubMed
19.
go back to reference de Magalhães JP, Curado J, Church GM: Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics. 2009, 25: 875-881. 10.1093/bioinformatics/btp073.PubMedCentralCrossRefPubMed de Magalhães JP, Curado J, Church GM: Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics. 2009, 25: 875-881. 10.1093/bioinformatics/btp073.PubMedCentralCrossRefPubMed
20.
go back to reference Olsen N, Sokka T, Seehorn CL, Kraft B, Maas K, Moore J, Aune TM: A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells. Ann Rheum Dis. 2004, 63: 1387-1392. 10.1136/ard.2003.017194.PubMedCentralCrossRefPubMed Olsen N, Sokka T, Seehorn CL, Kraft B, Maas K, Moore J, Aune TM: A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells. Ann Rheum Dis. 2004, 63: 1387-1392. 10.1136/ard.2003.017194.PubMedCentralCrossRefPubMed
Metadata
Title
Early and long-standing rheumatoid arthritis: distinct molecular signatures identified by gene-expression profiling in synovia
Authors
Thierry Lequerré
Carine Bansard
Olivier Vittecoq
Céline Derambure
Martine Hiron
Maryvonne Daveau
François Tron
Xavier Ayral
Norman Biga
Isabelle Auquit-Auckbur
Gilles Chiocchia
Xavier Le Loët
Jean-Philippe Salier
Publication date
01-06-2009
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 3/2009
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2744

Other articles of this Issue 3/2009

Arthritis Research & Therapy 3/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine